# Efficacy of Lodotra®(Prednisone) in Reduction of Morning Stiffness Duration(K-IMPROvE)

> **NCT02072200** · PHASE4 · COMPLETED · sponsor: **Mundipharma Korea Ltd** · enrollment: 147 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Lodotra®

## Key facts

- **NCT ID:** NCT02072200
- **Lead sponsor:** Mundipharma Korea Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2016-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02072200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02072200, "Efficacy of Lodotra®(Prednisone) in Reduction of Morning Stiffness Duration(K-IMPROvE)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02072200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*